Systemic inflammatory response syndrome caused by chronic salicylate intoxication

Naga Chalasani, Jesse Roman, Rafael L. Jurado

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Systemic inflammatory response syndrome (SIRS) is characterized by body temperature abnormalities, tachypnea or hyperventilation, tachycardia, and leukocytosis or leukopenia. Although it is typically associated with a serious infection and referred to as sepsis, SIRS can stem from noninfectious causes, as well. We report the cases of four patients with toxic serum levels of salicylate (33.5 to 67.6 mg/dL) and SIRS, and we discuss mechanisms responsible for SIRS. Our patients showed temperature disturbances (35.5°C to 39.8°C), noncardiogenic pulmonary edema, and mixed acid base disturbances. Other abnormalities included coagulopathy (disseminated intravascular coagulation), encephalopathy, and hypotension. All four patients recovered from SIRS, probably due to early recognition and treatment; only one patient did not survive the hospitalization. Chronic salicylate toxicity should be considered as a cause of SIRS in the absence of a source of infection, since survival appears to be dependent on prompt diagnosis and management.

Original languageEnglish (US)
Pages (from-to)479-482
Number of pages4
JournalSouthern Medical Journal
Volume89
Issue number5
DOIs
StatePublished - May 1996
Externally publishedYes

Fingerprint

Systemic Inflammatory Response Syndrome
Salicylates
Tachypnea
Hyperventilation
Disseminated Intravascular Coagulation
Poisons
Leukocytosis
Leukopenia
Brain Diseases
Pulmonary Edema
Infection
Body Temperature
Tachycardia
Hypotension
Sepsis
Hospitalization
Temperature
Acids
Survival
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Systemic inflammatory response syndrome caused by chronic salicylate intoxication. / Chalasani, Naga; Roman, Jesse; Jurado, Rafael L.

In: Southern Medical Journal, Vol. 89, No. 5, 05.1996, p. 479-482.

Research output: Contribution to journalArticle

Chalasani, Naga ; Roman, Jesse ; Jurado, Rafael L. / Systemic inflammatory response syndrome caused by chronic salicylate intoxication. In: Southern Medical Journal. 1996 ; Vol. 89, No. 5. pp. 479-482.
@article{b414129226c346c9a73332fcedfc6a2a,
title = "Systemic inflammatory response syndrome caused by chronic salicylate intoxication",
abstract = "Systemic inflammatory response syndrome (SIRS) is characterized by body temperature abnormalities, tachypnea or hyperventilation, tachycardia, and leukocytosis or leukopenia. Although it is typically associated with a serious infection and referred to as sepsis, SIRS can stem from noninfectious causes, as well. We report the cases of four patients with toxic serum levels of salicylate (33.5 to 67.6 mg/dL) and SIRS, and we discuss mechanisms responsible for SIRS. Our patients showed temperature disturbances (35.5°C to 39.8°C), noncardiogenic pulmonary edema, and mixed acid base disturbances. Other abnormalities included coagulopathy (disseminated intravascular coagulation), encephalopathy, and hypotension. All four patients recovered from SIRS, probably due to early recognition and treatment; only one patient did not survive the hospitalization. Chronic salicylate toxicity should be considered as a cause of SIRS in the absence of a source of infection, since survival appears to be dependent on prompt diagnosis and management.",
author = "Naga Chalasani and Jesse Roman and Jurado, {Rafael L.}",
year = "1996",
month = "5",
doi = "10.1097/00007611-199605000-00005",
language = "English (US)",
volume = "89",
pages = "479--482",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Systemic inflammatory response syndrome caused by chronic salicylate intoxication

AU - Chalasani, Naga

AU - Roman, Jesse

AU - Jurado, Rafael L.

PY - 1996/5

Y1 - 1996/5

N2 - Systemic inflammatory response syndrome (SIRS) is characterized by body temperature abnormalities, tachypnea or hyperventilation, tachycardia, and leukocytosis or leukopenia. Although it is typically associated with a serious infection and referred to as sepsis, SIRS can stem from noninfectious causes, as well. We report the cases of four patients with toxic serum levels of salicylate (33.5 to 67.6 mg/dL) and SIRS, and we discuss mechanisms responsible for SIRS. Our patients showed temperature disturbances (35.5°C to 39.8°C), noncardiogenic pulmonary edema, and mixed acid base disturbances. Other abnormalities included coagulopathy (disseminated intravascular coagulation), encephalopathy, and hypotension. All four patients recovered from SIRS, probably due to early recognition and treatment; only one patient did not survive the hospitalization. Chronic salicylate toxicity should be considered as a cause of SIRS in the absence of a source of infection, since survival appears to be dependent on prompt diagnosis and management.

AB - Systemic inflammatory response syndrome (SIRS) is characterized by body temperature abnormalities, tachypnea or hyperventilation, tachycardia, and leukocytosis or leukopenia. Although it is typically associated with a serious infection and referred to as sepsis, SIRS can stem from noninfectious causes, as well. We report the cases of four patients with toxic serum levels of salicylate (33.5 to 67.6 mg/dL) and SIRS, and we discuss mechanisms responsible for SIRS. Our patients showed temperature disturbances (35.5°C to 39.8°C), noncardiogenic pulmonary edema, and mixed acid base disturbances. Other abnormalities included coagulopathy (disseminated intravascular coagulation), encephalopathy, and hypotension. All four patients recovered from SIRS, probably due to early recognition and treatment; only one patient did not survive the hospitalization. Chronic salicylate toxicity should be considered as a cause of SIRS in the absence of a source of infection, since survival appears to be dependent on prompt diagnosis and management.

UR - http://www.scopus.com/inward/record.url?scp=0030007459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030007459&partnerID=8YFLogxK

U2 - 10.1097/00007611-199605000-00005

DO - 10.1097/00007611-199605000-00005

M3 - Article

C2 - 8638172

AN - SCOPUS:0030007459

VL - 89

SP - 479

EP - 482

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 5

ER -